Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral ...
SPR ®, a leading private medical device company focused on improving the lives of millions of people living with pain, announced that Aetna has published an updated medical policy that designates the ...
A new study reveals how the brain triggers the breakdown of stable fat cells that normally resist diet and exercise. This ...
Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ...
Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction ...
Study reveals glioblastoma tumors exploit sugar metabolism to suppress immune responses, suggesting new immunotherapy targets ...
From mosquitoes to fire ants and kissing bugs, some of Florida’s most common insects can carry disease or venom that makes a ...
Peptide conjugation techniques are advancing CNS delivery of oligonucleotides, addressing blood-brain barrier challenges and improving therapeutic outcomes.
Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.
Evidence suggests reactivations of the varicella-zoster virus may accelerate aging and raise dementia risk. Now scientists want to know if vaccines and antivirals could help protect the brain.
Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results